Blue Cross and Blue Shield of Montana prior authorization, page 37
CPT code lookup
Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.
Prior authorization codes
| Code | Description | Source |
|---|---|---|
| J9275 | Unloxcyt (cosibelimab-ipdl) | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 19 Original policy |
| J9276 | Ziihera (zanidatamab-hrii) | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 19 Original policy |
| J9277 | Keytruda Qlex Carelon (pembrolizumab and berahyaluronidase alfa- pmph) | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9281 | Mitomycin Pyelocalyceal Carelon Instillation 1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9282 | mitomycin | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9286 | Injection Glofitamab-Gxbm Carelon 2.5 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9289 | Opdivo Qvantig (nivolumab Carelon hyaluronidase-nvhy) | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9295 | Injection Necitumumab 1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9298 | Injection Nivolumab And Carelon Relatlimab-Rmbw 3 Mg/1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9299 | Injection Nivolumab 1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9301 | Injection Obinutuzumab 10 Carelon or Mg BCBSMT | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9302 | Injection Ofatumumab 10 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9303 | Injection Panitumumab 10 Carelon Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9306 | Injection Pertuzumab 1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9308 | Injection Ramucirumab 5 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9309 | Injection Polatuzumab Carelon Vedotin-Piiq 1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 20 Original policy |
| J9311 | Injection Rituximab 10 Mg Carelon And Hyaluronidase | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9312 | Injection Rituximab 10 Mg Carelon or BCBSMT | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9316 | Injection Pertuzumab Carelon Trastuzumab And Hyaluronidase-Zzxf Per 10 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9317 | Injection Sacituzumab Carelon Govitecan-Hziy 2.5 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9321 | Injection Epcoritamab-Bysp Carelon 0.16 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9325 | Injection Talimogene Carelon Laherparepvec Per 1 Million Plaque Forming Units | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9326 | telisotuzumab vedotin-tllv | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9329 | Injection, tislelizumab-jsgr, Carelon 1mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9331 | Injection Sirolimus Protein- Carelon Bound Particles 1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9332 | Injection Efgartigimod Alfa- BCBSMT Fcab 2Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9333 | Injection, rozanolixizumab- BCBSMT noli, 1 mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9334 | Injection, efgartigimod alfa, 2 BCBSMT mg and hyaluronidase-qvfc | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9345 | Injection Retifanlimab-Dlwr 1 Carelon Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9347 | Injection Tremelimumab-Actl Carelon 1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 21 Original policy |
| J9348 | Injection Naxitamab-Gqgk 1 Carelon Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9349 | Injection Tafasitamab-Cxix 2 Carelon Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9350 | Injection Mosunetuzumab- Carelon Axgb 1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9352 | Injection Trabectedin 0.1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9353 | Injection Margetuximab- Carelon Cmkb 5 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9354 | Injection Ado-Trastuzumab Carelon Emtansine 1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9355 | Injection Trastuzumab Carelon Excludes Biosimilar 10 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9356 | Injection Trastuzumab 10 Mg Carelon And Hyaluronidase-Oysk | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9358 | Injection Fam-Trastuzumab Carelon Deruxtecan-Nxki 1 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9359 | Injection Loncastuximab Carelon Tesirine-Lpyl 0.075 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9361 | Ryzneuta (efbemalenograstim Carelon alfa-vuxw) | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9362 | Trabectedin | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9376 | Injection, pozelimab-bbfg, 1 BCBSMT mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9380 | Injection Teclistamab-Cqyv Carelon 0.5 Mg | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9381 | Tzield (teplizumab-mzwv) BCBSMT | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9382 | Bizengri (zenocutuzumab- Carelon zbco) | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9601 | Lynozyfic (linvoseltamab- Carelon gcpt) | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 22 Original policy |
| J9999 | Not Otherwise Classified Carelon Antineoplastic Drugs | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 23 Original policy |
| Q2041 | Axicabtagene Ciloleucel Up BCBSMT To 200 Million Autologous Anti- Cd19 Car Positive Viable T Cells Including Leukapheresis And Dose Preparation Procedures Per Therapeutic Dose | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 24 Original policy |
| Q2042 | Tisagenlecleucel Up To 600 BCBSMT Million Car-Positive Viable T Cells Including Leukapheresis And Dose Preparation Procedures Per Therapeutic Dose | 2026 Specialty Drugs and Infusion Site of Care Prior Authorization Code List, Pg 24 Original policy |